-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] In recent years, with the changes in the pharmaceutical market environment, the adjustment of pharmaceutical companies' business has accelerated, and layoffs have become more frequent in order to reduce costs and adapt to the market environme.
Judging from the published information, the overall layoffs of foreign pharmaceutical companies in 2021 are higher than that of local pharmaceutical compani.
Among them, three foreign-funded pharmaceutical companies, Arcadia Healthcare, AlerisLife, and Brookdale Senior Care, will lay off more than 10,000 employees, which will decrease respective.
19,700, 13,200, 12,000 employe.
Data shows that Arcadia Healthcare will have 42,200 employees in 2020, and only 22,500 in 202It is understood that on January 19, 2021, Arcadia Healthcare sold its UK operations to RemedcoUK Limited, a key reason for its significant reduction in sta.
It is reported that the company is a listed company that provides purely inpatient medical servic.
As of the end of 2021, the company operates 238 health care centers across the United States, with 10,500 beds serving mentally ill patients and providing drug treatme.
Management expects to utilize a number of strategies to maximize the size and geographic reach of the company, including the continuation of a national marketing strategy to attract new patients and referrals, increase the number of patients referred to other states of the company, and provide new and existing of patients to provide a wider range of services, and to expand the company's facilities and beds as need.
AlerisLife has 23,600 employees in 2020 and 10,400 employees in 202According to the information, AlerisLife I.
is a company established in 2001 under the laws of the state of Maryla.
The company operates senior living communities, including independent living communities, assisted living communities, and skilled nursing facilities, or SNFs, and provides ancillary services such as rehabilitation and wellness servic.
Recently, the company announced its financial repo.
The net profit attributable to common shareholders of the parent company in the first fiscal quarter of fiscal year 2022 was -73 million US dollars, a year-on-year decrease of 3951%; operating income was 173 million US dollars, a year-on-year decrease of 36
Brookdale Senior Care employs 45,000 people in 2020 and will decrease to 33,000 in 202This is a senior care enterprise, which occupies 10% of the market share of senior care services in the United Stat.
It operates about 1,055 senior care service facilities of various types in 47 states in the United States, providing services to more than 100,000 custome.
According to the financial report, the company's 2021 annual report net profit attributable to common shareholders of the parent company was -929 million US dollars, a year-on-year decrease of 2206%; operating income was 758 billion US dollars, a year-on-year decrease of 20
Among domestic pharmaceutical companies, according to Wind data, the largest number of layoffs in the two cities is Great Health International, and the number of layoffs in 2021 will exceed 2,000, followed by Kangyuan Pharmaceutical, Sunshine Pharmaceutical, Shanghai Pharmaceuticals, and Sinopharm Hyundai and others have reduced the number of employees by more than 1,00From the perspective of abolished positions, mainly sales are the main on.
Among them, Kangyuan Pharmaceutical will reduce 1,407 employees in 2021, while sales personnel will reach 1,28Shanghai Pharmaceuticals will have a net reduction of 1,080 employees in 2021, including 625 sales personn.
Regarding the reasons for layoffs, Shanghai Pharmaceuticals pointed out in its annual report that in terms of talent team, it will further improve the human resources system, optimize the distribution of talents, focus on core talents, and improve the quality of talen.
In addition, Hengrui revealed in the financial report, "In early 2021, the number of employees, institutional settings and the scale of business development do not match, resulting in high operating and personnel cos.
"In order to further reduce sales and operation costs and improve sales and operation efficiency, Hengrui Medicine will reduce nearly 4,000 sales staff in 2021, from about 17,000 at the beginning of the year to about 13,00Disclaimer: In any case, this article The information or opinions expressed in this document do not constitute investment advice to anyo.
Judging from the published information, the overall layoffs of foreign pharmaceutical companies in 2021 are higher than that of local pharmaceutical compani.
Among them, three foreign-funded pharmaceutical companies, Arcadia Healthcare, AlerisLife, and Brookdale Senior Care, will lay off more than 10,000 employees, which will decrease respective.
19,700, 13,200, 12,000 employe.
Data shows that Arcadia Healthcare will have 42,200 employees in 2020, and only 22,500 in 202It is understood that on January 19, 2021, Arcadia Healthcare sold its UK operations to RemedcoUK Limited, a key reason for its significant reduction in sta.
It is reported that the company is a listed company that provides purely inpatient medical servic.
As of the end of 2021, the company operates 238 health care centers across the United States, with 10,500 beds serving mentally ill patients and providing drug treatme.
Management expects to utilize a number of strategies to maximize the size and geographic reach of the company, including the continuation of a national marketing strategy to attract new patients and referrals, increase the number of patients referred to other states of the company, and provide new and existing of patients to provide a wider range of services, and to expand the company's facilities and beds as need.
AlerisLife has 23,600 employees in 2020 and 10,400 employees in 202According to the information, AlerisLife I.
is a company established in 2001 under the laws of the state of Maryla.
The company operates senior living communities, including independent living communities, assisted living communities, and skilled nursing facilities, or SNFs, and provides ancillary services such as rehabilitation and wellness servic.
Recently, the company announced its financial repo.
The net profit attributable to common shareholders of the parent company in the first fiscal quarter of fiscal year 2022 was -73 million US dollars, a year-on-year decrease of 3951%; operating income was 173 million US dollars, a year-on-year decrease of 36
Brookdale Senior Care employs 45,000 people in 2020 and will decrease to 33,000 in 202This is a senior care enterprise, which occupies 10% of the market share of senior care services in the United Stat.
It operates about 1,055 senior care service facilities of various types in 47 states in the United States, providing services to more than 100,000 custome.
According to the financial report, the company's 2021 annual report net profit attributable to common shareholders of the parent company was -929 million US dollars, a year-on-year decrease of 2206%; operating income was 758 billion US dollars, a year-on-year decrease of 20
Among domestic pharmaceutical companies, according to Wind data, the largest number of layoffs in the two cities is Great Health International, and the number of layoffs in 2021 will exceed 2,000, followed by Kangyuan Pharmaceutical, Sunshine Pharmaceutical, Shanghai Pharmaceuticals, and Sinopharm Hyundai and others have reduced the number of employees by more than 1,00From the perspective of abolished positions, mainly sales are the main on.
Among them, Kangyuan Pharmaceutical will reduce 1,407 employees in 2021, while sales personnel will reach 1,28Shanghai Pharmaceuticals will have a net reduction of 1,080 employees in 2021, including 625 sales personn.
Regarding the reasons for layoffs, Shanghai Pharmaceuticals pointed out in its annual report that in terms of talent team, it will further improve the human resources system, optimize the distribution of talents, focus on core talents, and improve the quality of talen.
In addition, Hengrui revealed in the financial report, "In early 2021, the number of employees, institutional settings and the scale of business development do not match, resulting in high operating and personnel cos.
"In order to further reduce sales and operation costs and improve sales and operation efficiency, Hengrui Medicine will reduce nearly 4,000 sales staff in 2021, from about 17,000 at the beginning of the year to about 13,00Disclaimer: In any case, this article The information or opinions expressed in this document do not constitute investment advice to anyo.
